Cargando…

Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study

OBJECTIVE: Ischemia-modified albumin (IMA) is a sensitive biomarker of myocardial ischemia. However, data on IMA levels in acute heart failure (HF) are still lacking. In this study, we aimed to evaluate serum IMA levels in acute decompensated HF and the effects of dobutamine and levosimendan treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Çavuşoğlu, Yüksel, Korkmaz, Şule, Demirtaş, Selda, Gencer, Erkan, Şaşmaz, Hatice, Mutlu, Fezan, Güneş, Hakan, Mert, Uğur Kadir, Özdemir, Sedat, Kalaycı, Süleyman, Yılmaz, Mehmet Birhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2016
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336859/ https://www.ncbi.nlm.nih.gov/pubmed/26301344 http://dx.doi.org/10.5152/akd.2015.6156

Ejemplares similares

Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
por: Juguet, William, et al.
Publicado: (2020)

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers
por: Bergh, Claes-Håkan, et al.
Publicado: (2010)

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Levosimendan versus dobutamine in cardiac surgery
por: Delgado-Amaya, MD, et al.
Publicado: (2015)

Levosimendan versus dobutamine in Tako-tsubo cardiomyopathy
por: Righetti, FR, et al.
Publicado: (2013)

The effects of levosimendan and dobutamine in experimental bupivacaine-induced cardiotoxicity
por: Kandemir, Ulku, et al.
Publicado: (2013)

Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism
por: Lyhne, Mads D., et al.
Publicado: (2021)

Clinical outcomes of levosimendan versus dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function
por: John, Basil, et al.
Publicado: (2021)

Combined effects of ivabradine with dobutamine or levosimendan in isolated perfused hearts
por: Konrad, D, et al.
Publicado: (2013)

The calcium sensitizer levosimendan reduces the brain natriuretic peptide levels as compared with dobutamine in intensive care unit septic patients with decompensated heart failure
por: Michalopoulou, H, et al.
Publicado: (2007)

The effects of levosimendan use on high-sensitivity C-reactive protein in patients with decompensated heart failure
por: Korkmaz, Hasan, et al.
Publicado: (2019)

Influence of temperature on the cardiac action of dobutamine and levosimendan in isolated perfused hearts
por: Aldenhoff, U, et al.
Publicado: (2013)

Levosimendan use in the emergency management of decompensated peripartum cardiomyopathy
por: Uriarte-Rodríguez, Alina, et al.
Publicado: (2010)

Newer treatments for decompensated heart failure: focus on levosimendan
por: Follath, Ferenc
Publicado: (2009)

Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis
por: Jaguszewski, Milosz J., et al.
Publicado: (2021)

Effect of β-blockade on the haemodynamic responses of levosimendan and dobutamine in the treatment of low-output heart failure
por: Follath, F, et al.
Publicado: (2002)

Levosimendan Versus Dobutamine in Myocardial Injury Patients with Septic Shock: A Randomized Controlled Trial
por: Meng, Jian-biao, et al.
Publicado: (2016)

Levosimendan versus dobutamine for sepsis-induced cardiac dysfunction: a systematic review and meta-analysis
por: Liu, Dong-Hua, et al.
Publicado: (2021)

Comparison of dobutamine and levosimendan for treatment of sepsis-induced cardiac dysfunction: A protocol for systematic review and meta-analysis
por: Guo, Jun, et al.
Publicado: (2022)

Levosimendan improves hemodynamic effects in patients with acutely decompensated heart failure: the Argentinean multicenter registry
por: Perrone, SV, et al.
Publicado: (2003)

Single-center experience with levosimendan in children undergoing cardiac surgery and in children with decompensated heart failure
por: Suominen, Pertti K
Publicado: (2011)

In vivo and in vitro evidence for pleiotropic effects of levosimendan in the intensive care setting
por: Yilmaz, Mehmet Birhan, et al.
Publicado: (2011)

IMA participating institutions conference on singularities
por: Randell, Richard C
Publicado: (1989)

Levosimendan treatment for acutely decompensated heart failure is as effective for Chagas disease patients as for patients with other etiologies
por: Pereira-Barretto, AC, et al.
Publicado: (2003)

Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double‐Blind Controlled Trial
por: Lannemyr, Lukas, et al.
Publicado: (2018)

Comparison of Semiparametric, Parametric, and Nonparametric ROC Analysis for Continuous Diagnostic Tests Using a Simulation Study and Acute Coronary Syndrome Data
por: Colak, Ertugrul, et al.
Publicado: (2012)

Study design of a mortality trial with intravenous levosimendan (the SURVIVE study) in patients with acutely decompensated heart failure
por: Mebazaa, A, et al.
Publicado: (2004)

IMA Conference on Mathematics Particle-physics Interface
por: Quillen, D G, et al.
Publicado: (1990)

3rd IMA Conference on Control Theory
Publicado: (1980)

Effect of Levosimendan on Acute Decompensated Right Heart Failure in Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: Qu, Chao, et al.
Publicado: (2022)

Renal and Neurologic Benefit of Levosimendan vs Dobutamine in Patients With Low Cardiac Output Syndrome After Cardiac Surgery: Clinical Trial FIM-BGC-2014-01
por: Guerrero-Orriach, Jose L., et al.
Publicado: (2020)

Image microarrays (IMA): Digital pathology's missing tool
por: Hipp, Jason, et al.
Publicado: (2011)

Bilateral skeletonized IMA: in situ grafts for myocardial revascularization
por: Jonjev, Z, et al.
Publicado: (2013)

The sigmoidea ima artery: A player in colonic ischemia?
por: Landen, Christoph, et al.
Publicado: (2020)

Regulation of the iron-deficiency response by IMA/FEP peptide
por: Tabata, Ryo
Publicado: (2023)

Catestatin in Acutely Decompensated Heart Failure Patients: Insights from the CATSTAT-HF Study
por: Borovac, Josip A., et al.
Publicado: (2019)

Isoflavone Malonyltransferases GmIMaT1 and GmIMaT3 Differently Modify Isoflavone Glucosides in Soybean (Glycine max) under Various Stresses
por: Ahmad, Muhammad Z., et al.
Publicado: (2017)

Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
por: McLean, AS, et al.
Publicado: (2003)

Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure
por: Lee, Wei-Chieh, et al.
Publicado: (2022)

Comparison of Levosimendan versus Dobutamine in Patients with Moderate to Severe Left Ventricular Dysfunction Undergoing Off-pump Coronary Artery Bypass Grafting: A Randomized Prospective Study
por: Kandasamy, Ashok, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_th77nj2ec6p24udac72c5fe8a0